NEW YORK, Sept. 8 (GenomeWeb News) - Linden Bioscience has signed a deal to provide its Tilia oligonucloetide probe design service to Dutch biotech firm PamGene International, the companies said today.

PamGene plans to use the probes with its 5D-Pulse microarray platform, which is the basis for the company's FD10 system and soon-to-be launched PamStation 96 microarray system.

Specific terms of the arrangement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.